Bigdon, E.; Steinhorst, N.A.; Weissleder, S.; Durchkiv, V.; Stübiger, N.
Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory? J. Clin. Med. 2022, 11, 2419.
https://doi.org/10.3390/jcm11092419
AMA Style
Bigdon E, Steinhorst NA, Weissleder S, Durchkiv V, Stübiger N.
Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory? Journal of Clinical Medicine. 2022; 11(9):2419.
https://doi.org/10.3390/jcm11092419
Chicago/Turabian Style
Bigdon, Eileen, Nils Alexander Steinhorst, Stephanie Weissleder, Vasyl Durchkiv, and Nicole Stübiger.
2022. "Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory?" Journal of Clinical Medicine 11, no. 9: 2419.
https://doi.org/10.3390/jcm11092419
APA Style
Bigdon, E., Steinhorst, N. A., Weissleder, S., Durchkiv, V., & Stübiger, N.
(2022). Treatment in Latent Tuberculosis Uveitis—Is Immunosuppression Effective or Is Conventional 3- or 4-Drug Antituberculosis Therapy Mandatory? Journal of Clinical Medicine, 11(9), 2419.
https://doi.org/10.3390/jcm11092419